Table 7 Multivariate Cox regression analysis of factors affecting disease free survival
From: Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma
Prognostic factor | p-value | Hazard ratio | 95% Confidence intervals |
|---|---|---|---|
Age | 0.466 | 1.013 | 0.979–1.048 |
TNM Stage | < 0.001 |  |  |
 Stage I vs Stage III | 0.007 | 0.114 | 0.024–0.550 |
 Stage II vs Stage III | < 0.001 | 0.181 | 0.077–0.427 |
Nottingham grade | 0.358 | Â | Â |
 Grade 2 vs Grade 1 | 0.193 | 0.518 | 0.193–1.394 |
 Grade 3 vs Grade 1 | 0.773 | 0.862 | 0.313–2.371 |
Margin involvement (Involved vs Uninvolved) | 0.970 | 0.976 | 0.281–3.385 |
Molecular subtype | 0.283 | Â | Â |
 HER 2 vs Luminal | 0.700 | 0.732 | 0.149–3.589 |
 TNBC vs Luminal | 0.282 | 2.090 | 0.545–8.012 |
ER/AR Status | 0.023 | Â | Â |
 ER+/AR+ vs ER−/AR- | 0.792 | 1.214 | 0.288–5.107 |
 ER+/AR- vs ER−/AR- | 0.079 | 3.308 | 0.870–12.580 |
 ER−/AR+ vs ER−/AR- | 0.014 | 3.537 | 1.286–9.730 |